Literature DB >> 14637265

Myoglobin stratifies short-term risk in acute major pulmonary embolism.

Piotr Pruszczyk1, Anna Bochowicz, Maciej Kostrubiec, Adam Torbicki, Marcin Szulc, Hubert Gurba, Krystyna Kuczynska, Hanna Berent.   

Abstract

BACKGROUND: Concentrations of cardiac troponins can be elevated in acute pulmonary embolism (APE) indicating myocardial injury. Although concentration of myoglobin (MYO) increases after myocardial damage, even before detectable rise of cardiac troponin levels occurs, MYO was not evaluated in APE. Therefore, we assessed prevalence and prognostic significance of myoglobin in major APE.
METHODS: We studied 46 patients (30 women, aged 61.9+/-17.8 years) with major APE defined with right ventricular dilatation. On admission serum myoglobin, and cardiac troponin T (cTnT) were measured. Serum MYO concentrations >58 ng/ml for women, and >72 ng/ml for men were considered abnormal. CTnT>0.01 ng/ml was regarded to indicate myocardial injury.
RESULTS: MYO levels exceeding sex specific norms were found in 21/46 (45.7%) of patients, while detectable cTnT was found in 24/46 (52.1%) of patients. Seven patients died during hospitalization. Elevated MYO significantly predicted in-hospital mortality (OR 25, 95% CI 1.3-474.2), while increased cTnT concentration did not affect the survival. Among clinical and echocardiographic variables only older age indicated worse prognosis (OR 1.6, 95% CI 1.06-2.41).
CONCLUSIONS: Myoglobin levels are elevated in serum on admission in almost half of patients with major APE. Elevated myoglobin level, marker of myocardial injury, is a powerful predictor of increased risk of fatal outcome in major pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637265     DOI: 10.1016/j.cccn.2003.07.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Plasma copeptin for short term risk stratification in acute pulmonary embolism.

Authors:  Anna Wyzgał; Marcin Koć; Szymon Pacho; Maksymilian Bielecki; Radosław Wawrzyniak; Maciej Kostrubiec; Michał Ciurzyński; Katarzyna Kurnicka; Sylwia Goliszek; Marzena Paczyńska; Piotr Palczewski; Piotr Pruszczyk
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

2.  Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19.

Authors:  Anamika Gupta; Abaher O Al-Tamimi; Rabih Halwani; Hend Alsaidi; Meganathan Kannan; Firdos Ahmad
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-23

Review 3.  Diagnosis of pulmonary embolism in the coronary care unit.

Authors:  Paul D Stein; H Dirk Sostman; Russell D Hull; Lawrence R Goodman; Kenneth V Leeper; Alexander Gottschalk; Victor F Tapson; Pamela K Woodard
Journal:  Am J Cardiol       Date:  2009-01-24       Impact factor: 2.778

Review 4.  Acute pulmonary embolism: risk stratification in the emergency department.

Authors:  C Becattini; G Agnelli
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

5.  Prognostic value of serum myoglobin in patients after cardiac surgery.

Authors:  Denis Hofmann; Marco Buettner; Florian Rissner; Manuela Wahl; Samir G Sakka
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

Review 6.  Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers.

Authors:  Luca Masotti; Marc Righini; Nicolas Vuilleumier; Fabio Antonelli; Giancarlo Landini; Roberto Cappelli; Patrick Ray
Journal:  Vasc Health Risk Manag       Date:  2009-07-14

7.  Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism.

Authors:  Neşe Dursunoğlu; Dursun Dursunoğlu; Ali İhsan Yıldız; Simin Rota
Journal:  Anatol J Cardiol       Date:  2014-12-31       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.